Clinical proof demand outrages UK supplement makers; CRO goes CDISC;
> U.K. supplement makers and health food manufacturers are angry that regulators are beginning to demand clinical data that supports label claims. Blog | Video
> CRO Max Neeman International now offers CDISC services and modified solutions, including ongoing and legacy clinical data conversion, implementation of CDISC standards and CDISC compliance checks. Release
> Mobile drug reference tool maker Epocrates has named Jake Winebaum, an Internet incubator co-founder, to its board. Release
> Bay Clinic in Hawaii will receive $805,000 in stimulus funding over two years to support information technology improvements including hardware, a data center and enhancements to electronic practice management. Article
> The Patient Recruitment Organization has elected Robert Loll as vice chairman. Release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: